Management of rejection, with reference to the kidney.
Power
D
D
Department of Clinical Immunology, St Vincent's Hospital, Fitzroy, Vic.
d'Apice
T
T
D016572:Cyclosporine / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000635:transmission; D006084:Graft Rejection / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine